|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Phase I and Pharmacokinetic
Study of the Novel Redox-Active Agent, Motexafin Gadolinium,
with Concurrent Radiation Therapy in Patients with Locally Advanced
Pancreatic or Biliary Cancers Cancer Chemother Pharmacol. 2005 Aug 25;:1-10. PMID: 16133531
|
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |